Enfermedades Infecciosas
Buscador de publicaciones
Sólo se han incluido artículos originales, editoriales y revisiones.
-
Moreno Guillen S, Losa García JE, Berenguer Berenguer J, Martínez Sesmero JM, Cenoz Gomis S, Graefenhain R, Lopez Sanchez-Cambronero D, Parrondo Garcia FJ.
Cost-utility analysis of the fixed-dose combination of dolutegravir/abacavir/lamivudine as initial treatment of HIV+ patients in Spain.
FARMACIA HOSPITALARIA . 41(5): 601-610.
-
Sanchez Conde M, Vivancos Gallego MJ, Moreno Guillen S.
Pre-exposure prophylaxis (PrEP) against HIV: efficacy, safety and uncertainties.
FARMACIA HOSPITALARIA . 41(5): 630-637.
-
Fernández-Ruiz M, Guinea J, Lora-Pablos D, Zaragoza Ó, Puig-Asensio M, Almirante B, Cuenca-Estrella M, Aguado JM, CANDIPOP Project, GEIH-GEMICOMED (SEIMC) and REIPI.
Impact of fluconazole susceptibility on the outcome of patients with candidaemia: data from a population-based surveillance.
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases . 23(9): . Nº de citas: 18
-
Serrano-Villar S, Vázquez-Castellanos JF, Vallejo A, Latorre A, Sainz T, Ferrando-Martínez S, Rojo D, Martínez-Botas J, Del Romero J, Madrid N, Leal M, Mosele JI, Motilva MJ, Barbas C, Ferrer M, Moya A, Moreno S, Gosalbes MJ, Estrada V.
The effects of prebiotics on microbial dysbiosis, butyrate production and immunity in HIV-infected subjects.
MUCOSAL IMMUNOLOGY . 10(5): 1279-1293. Nº de citas: 61
-
Navarro M, Monge-Maíllo B, Flores-Chavez MD, López-Vélez R.
Hunting hidden parasites: Trypanosoma cruzi.
Lancet (London, England) . 390(10096): 724-726. Nº de citas: 12
-
Gudiol C, Royo-Cebrecos C, Abdala E, Akova M, Álvarez R, Maestro-de la Calle G, Cano A, Cervera C, Clemente WT, Martín-Dávila P, Freifeld A, Gómez L, Gottlieb T, Gurguí M, Herrera F, Manzur A, Maschmeyer G, Meije Y, Montejo M, Peghin M, Rodríguez-Baño J, Ruiz-Camps I, Sukiennik TC, Tebe C, Carratalà J, BICAR Study Group.
Efficacy of ß-Lactam/ß-Lactamase Inhibitor Combinations for the Treatment of Bloodstream Infection Due to Extended-Spectrum-ß-Lactamase-Producing Enterobacteriaceae in Hematological Patients with Neutropenia.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY . 61(8): . Nº de citas: 31
-
Berenguer J, Rodríguez-Castellano E, Carrero A, Von Wichmann MA, Montero M, Galindo MJ, Mallolas J, Crespo M, Téllez MJ, Quereda C, Sanz J, Barros C, Tural C, Santos I, Pulido F, Guardiola JM, Rubio R, Ortega E, Montes ML, Jusdado JJ, Gaspar G, Esteban H, Bellón JM, González-García J.
Eradication of hepatitis C virus and non-liver-related non-acquired immune deficiency syndrome-related events in human immunodeficiency virus/hepatitis C virus coinfection.
HEPATOLOGY . 66(2): 344-356. Nº de citas: 42
-
Poveda E, Hernández-Quero J, Pérez-Elías MJ, Ribas MA, Martínez-Madrid OJ, Flores J, Navarro J, Gutiérrez F, García-Deltoro M, Imaz A, Ocampo A, Artero A, Blanco F, Bernal E, Pasquau J, Mínguez-Gallego C, Pérez N, Aiestaran A, García F, Paredes R.
Genotypic tropism testing of proviral DNA to guide maraviroc initiation in aviraemic subjects: 48-week analysis of results from the PROTEST study.
HIV MEDICINE . 18(7): 482-489. Nº de citas: 1
-
Henriquez-Camacho C, Villafuerte-Gutierrez P, Pérez-Molina JA, Losa J, Gotuzzo E, Cheyne N.
Opt-out screening strategy for HIV infection among patients attending emergency departments: systematic review and meta-analysis.
HIV MEDICINE . 18(6): 419-429. Nº de citas: 20
-
Lora-Tamayo J, Senneville É, Ribera A, Bernard L, Dupon M, Zeller V, Li HK, Arvieux C, Clauss M, Uçkay I, Vigante D, Ferry T, Iribarren JA, Peel TN, Sendi P, Miksic NG, Rodríguez-Pardo D, Del Toro MD, Fernández-Sampedro M, Dapunt U, Huotari K, Davis JS, Palomino J, Neut D, Clark BM, Gottlieb T, Trebše R, Soriano A, Bahamonde A, Guío L, Rico A, Salles MJ, Pais MJ, Benito N, Riera M, Gómez L, Aboltins CA, Esteban J, Horcajada JP, O'Connell K, Ferrari M, Skaliczki G, San Juan R, Cobo J, Sánchez-Somolinos M, Ramos A, Giannitsioti E, Jover-Sáenz A, Baraia-Etxaburu JM, Barbero JM, Choong PF, Asseray N, Ansart S, Le Moal G, Zimmerli W, Ariza J, and the Group of Investigators for Streptococcal Prosthetic Joint Infection..
The Not-So-Good Prognosis of Streptococcal Periprosthetic Joint Infection Managed by Implant Retention: The Results of a Large Multicenter Study.
CLINICAL INFECTIOUS DISEASES . 64(12): 1742-1752. Nº de citas: 53
-
Ortiz-Flores A, Gioia F, Montánez-Fernández L, Santacruz E, Martín-Dávila P, Pian-Arias H, Botella-Carretero JI.
Incidental finding of a primary thyroid tuberculosis.
Oxford Medical Case Reports . 2017(6): . Nº de citas: 3
-
González-García A, Fortún J, Elorza Navas E, Martín-Dávila P, Tato M, Gómez-Mampaso E, Moreno S.
The changing epidemiology of tuberculosis in a Spanish tertiary hospital (1995-2013).
Medicine . 96(26): . Nº de citas: 8
-
Castón JJ, Lacort I, Martín-Dávila P, Loeches B, Tabares S, Temkin L, Torre-Cisneros J, Paño JR.
Clinical efficacy of ceftazidime/avibactam versus other active agents for the treatment of bacteremia due to carbapenemase-producing Enterobacteriaceae in hematologic patients.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES . 59: 118-123. Nº de citas: 69
-
Caniglia EC, Cain LE, Sabin CA, Robins JM, Logan R, Abgrall S, Mugavero MJ, Hernández-Díaz S, Meyer L, Seng R, Drozd DR, Seage GR, Bonnet F, Dabis F, Moore RD, Reiss P, van Sighem A, Mathews WC, Del Amo J, Moreno S, Deeks SG, Muga R, Boswell SL, Ferrer E, Eron JJ, Napravnik S, Jose S, Phillips A, Justice AC, Tate JP, Gill J, Pacheco A, Veloso VG, Bucher HC, Egger M, Furrer H, Porter K, Touloumi G, Crane H, Miro JM, Sterne JA, Costagliola D, Saag M, Hernán MA, HIV-CAUSAL Collaboration, Centers for AIDS Research Network of Integrated Clinical Systems.
Comparison of dynamic monitoring strategies based on CD4 cell counts in virally suppressed, HIV-positive individuals on combination antiretroviral therapy in high-income countries: a prospective, observational study.
The lancet. HIV . 4(6): . Nº de citas: 8
-
Muñoz P, Vena A, Padilla B, Valerio M, Sanchez MI, Puig-Asensio M, Fortún J, Fernández-Ruiz M, Merino P, Losa JE, Loza A, Rivas RA, Bouza E, CANDIPOP Project, GEIH-GEMICOMED (SEIMC), and REIPI.
No evidence of increased ocular involvement in candidemic patients initially treated with echinocandins.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE . 88(2): 141-144. Nº de citas: 19
-
Moreno S, Antela A, García F, Del Amo J, Boix V, Coll P, Fortuny C, Sirvent JL, Gutiérrez F, Iribarren JA, Llibre JM, Quirós JC, Losa JE, Lozano A, Meulbroek M, Olalla J, Pujol F, Pulido F, Crespo Casal M, García JG, Aldeguer JL, Molina JA, Podzamczer Palter D, Román AR, Grupo Redactor de GESIDA/SEIMC.
Executive summary: Pre-exposure prophylaxis for prevention of HIV infection in adults in Spain: July 2016.
ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA . 35(6): 377-383. Nº de citas: 8
-
Masiá M, Padilla S, Fernández M, Barber X, Moreno S, Iribarren JA, Portilla J, Peña A, Vidal F, Gutiérrez F, CoRIS.
Contribution of Oxidative Stress to Non-AIDS Events in HIV-Infected Patients.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES . 75(2): . Nº de citas: 6
-
López-Huertas MR, Jiménez-Tormo L, Madrid-Elena N, Gutiérrez C, Rodríguez-Mora S, Coiras M, Alcamí J, Moreno S.
The CCR5-antagonist Maraviroc reverses HIV-1 latency in vitro alone or in combination with the PKC-agonist Bryostatin-1.
SCIENTIFIC REPORTS . 7(1): 2385-2385. Nº de citas: 32